SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Tejeda HA, Green SB, Trimble EL, et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst. 1996; 88: 812816.
  • 2
    Benson A. Institutional perspectives on minority population recruitment to cancer clinical trials. Recruitment and Retention of Minority Participants in Clinical Cancer Research: conference summary. Washington, DC: National Institutes of Health and National Cancer Institute, 1996.
  • 3
    Alexander GA, Chu KC, Ho RC. Representation of Asian Americans in clinical cancer trials. Ann Epidemiol. 2000; 10(8 Suppl ): S61S67.
  • 4
    Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004; 291: 27202726.
  • 5
    Corbie-Smith G, Miller WC, Ransohoff DF. Interpretations of ‘appropriate’ minority inclusion in clinical research. Am J Med. 2004; 116: 249252.
  • 6
    Chu KC. Cancer data for Asian Americans and Pacific Islanders. Asian Am Pac Isl J Health. 1998; 6: 130139.
  • 7
    MillerBA, KolonelLN, BernsteinL, YoungJL, et al., editors. Racial/ethnic patterns of cancer in the United States 1988–1992. Bethesda, MD: National Cancer Institute, 1996.
  • 8
    Parker SL, Davis KJ, Wingo PA, Ries LA, Heath CW Jr. Cancer statistics by race and ethnicity. CA Cancer J Clin. 1998; 48: 3148.
  • 9
    Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998; 90: 13711388.
  • 10
    Cuzick J, Forbes J, Edwards R, et al. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet. 2002; 360: 817824.
  • 11
    Cauley JA, Norton L, Lippman ME, et al. Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple Outcomes of Raloxifene Evaluation. Breast Cancer Res Treat. 2001; 65: 125134.
  • 12
    Vogel VG. Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts. Clin Cancer Res. 2001; 7(12 Suppl ): 4413s4418s; discussion, 4411s–4412s.
  • 13
    Association of Asian Pacific Community Health Organizations. Capacity-building initiative for Asian American and Pacific Islanders to participate in clinical research studies: summary report of needs assessment. Oakland, CA: Association of Asian Pacific Community Health Organizations, 2000.
  • 14
    Kinney AY, Richards C, Vernon SW, Vogel VG. The effect of physician recommendation on enrollment in the Breast Cancer Chemoprevention Trial. Prev Med. 1998; 27(5 Pt 1): 713719.
  • 15
    Nguyen TT, McPhee S, Nguyen T, Lam T, Mock J. Predictors of cervical Pap smear screening awareness, intention, and receipt among Vietnamese-American women. Am J Prev Med. 2002; 23: 207214.
  • 16
    Lee MM, Lee F, Stewart S, McPhee S. Cancer screening practices among primary care physicians serving Chinese Americans in San Francisco. Western J Med. 1999; 170: 148155.
  • 17
    Jenkins CN, McPhee SJ, Bird JA, et al. Effect of a media-led education campaign on breast and cervical cancer screening among Vietnamese-American women. Prev Med. 1999; 28: 395406.
  • 18
    Bureau of the Census. Table DP-1. Profile of general demographic characteristics: Census 2000 summary file 1 (SF 1) 100-percent data. Geographic area: San Francisco and Santa Clara County, California. Washington, DC: Bureau of the Census, 2000.
  • 19
    Kaluzny AD, Lacey LM, Warnecke R, Morrissey JP, Sondik EJ, Ford L. Accrual of patients to randomized clinical trials. Factors affecting cancer prevention and control research. Int J Technol Assess Health Care. 1994; 10: 506516.
  • 20
    Mansour EG. Barriers to clinical trials. Part III: knowledge and attitudes of health care providers. Cancer. 1994; 74(9 Suppl ): 26722675.
  • 21
    Brown DR, Fouad MN, Basen-Engquist K, Tortolero-Luna G. Recruitment and retention of minority women in cancer screening, prevention, and treatment trials. Ann Epidemiol. 2000; 10(8 Suppl ): S13S21.
  • 22
    Crosson K, Eisner E, Brown C, Ter Maat J. Primary care physicians' attitudes, knowledge, and practices related to cancer clinical trials. J Cancer Educ. 2001; 16: 188192.
  • 23
    McCaskill-Stevens W, Pinto H, Marcus AC, et al. Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association. J Clin Oncol. 1999; 17: 10291039.
  • 24
    Pinto HA, McCaskill-Stevens W, Wolfe P, Marcus AC. Physician perspectives on increasing minorities in cancer clinical trials: an Eastern Cooperative Oncology Group (ECOG) initiative. Ann Epidemiol. 2000; 10(8 Suppl ): S78S84.
  • 25
    Chen AM. Demographic characteristics of Asian and Pacific Islander Americans: health implications. Asian Am Pac Isl J Health. 1996; 4(1–3): 4049.
  • 26
    Reeves TJ, Bennett CE. We the people: Asians in the United States, Washington, D.C.: U.S. Census Bureau, 2004.
  • 27
    Weech-Maldonado R, Elliott MN, Morales LS, Spritzer K, Marshall GN, Hays RD. Health plan effects on patient assessments of Medicaid managed care among racial/ethnic minorities. J Gen Intern Med. 2004; 19: 136145.
  • 28
    Ngo-Metzger Q, Massagli MP, Clarridge BR, et al. Linguistic and cultural barriers to care. J Gen Intern Med. 2003; 18: 4452.
  • 29
    Napoles-Springer A, Grumbach K, Alexander M, et al. Clinical research with older African Americans and Latinos. Res Aging. 2000; 22: 668691.
  • 30
    Schain WS. Barriers to clinical trials. Part II: knowledge and attitudes of potential participants. Cancer. 1994; 74(9 Suppl ): 26662671.
  • 31
    Emanuel E. ASCO survey of oncologists on clinical research. Presented at American Society of Clinical Oncologists Annual Meeting, May 15–18, 1999; Atlanta, GA.
  • 32
    Kaluzny A, Brawley O, Garson-Angert D, et al. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program. J Natl Cancer Inst. 1993; 85: 19451950.
  • 33
    Brawley OW. The study of accrual to clinical trials: can we learn from studying who enters our studies? J Clin Oncol. 2004; 22: 20392040.